Beijing (1)

Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma (1)

Neoadjuvant or Conversion Therapy (1)

Precision Therapy (1)

Recruiting (1)

phase 2 (1)

Peking Union Medical College (1)

Peking University Hospital of Stomatology (1)

albumin paclitaxel with platinum (1)

antiandrogen drug treatment (1)

larotinib or enttraitinib (1)

shr-a1921 (1)

small molecule multi-target tyrosine kinase inhibitors (1)

vedolizumab (1)

drug (1)

Other (1)

Interventional (1)

neoadjuvant or conversion therapy

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Nov 21, 2023